SlideShare a Scribd company logo
Method Validation
To understand College of American Pathologists
(CAP) requirements of method validation in a clinical
laboratory
Dr. Sibtain Ahmed
What is validation?
• “Validation is the process of testing a measurement
procedure to assess its performance and to determine
whether that performance is acceptable.” [CLSI]
Method Validation
Why must we validate?
When should we validate?
What should we validate?
What is method validation?
What is Method Validation?
–Method validation and/or verification is the process
by which a method is determined to be fit for
purpose and intended use.
–Although method validation/verification are often
used interchangeably, validation is usually
performed on in-house and/or modified methods,
while verification is taking a marketed/unmodified
assay and verifying its performance.
Purposes of Method Validation Studies
 To quantifiably characterize system performance
 To assess potential for error
 To identify method-to-method differences
 To meet regulatory guidelines
When to Do Method Validation Studies
 When considering purchasing a new system
 When placing a new system into service
 At regular intervals to assess on-going system performance
 When troubleshooting questionable system performance
Tests to Validate
• Waived tests are approved by the FDA for home use and by definition are
simple to perform (i.e., pregnancy test) – do not require validation.
• Non-waived tests included moderately and highly complex tests – requires
validation
• Degree of validation/verification depends on status of the test method (FDA-
approved/Non-FDA-approved/Modified/Unmodified)
• Unmodified FDA-approved: using as intended by the manufacturer and
licensed for use by the FDA
• Modified or Non-FDA approved: using test kit for indications other than as
intended by the manufacturer; not licensed for use by the FDA.
The 6 Elements of Method
Validation:
•If FDA-approved/Unmodified
– only Reportable Range,
Precision, Accuracy and
Reference Intervals need to be
verified.
•If Non-FDA
approved/Modified – all 6
elements must be performed,
including sensitivity and
specificity.
samples are analyzed according to any number of schemes depending
upon the analyte availability:
Twice a day in duplicate for 10 days.
Once a day for 20 days.
Twice a day in quadruplicate for 5 days.
Select sufficient material at two levels:
 Patient samples
 QC material
 Reference materials
 Standards
 Suitable materials that have a known value.
Precision
 Multiple measurements are close to each others
i.e. Reproducibility
 Gives information related to random error
Introduction
What is
needed
How we
perform the
testing
Experiment Design :
Run one sample 20 time once a day for within run precision and for between run
precision run one sample 2-4 times per day.
Data Input Requirements :
 20 reading of single specimen,
 allowable total error
 allowable random error
Statistics:
 MEAN
 SD
 CV
 2SD RANGE
 SD GOAL
Interpretation :The precision test pass if computed SD below the SD goal.
Accuracy
 How close to the true value Comparison of methods
 Closeness of the agreement between the result
of a measurement and a true value of the
measurand. [CLSI]
Gives information related to systematic error
Introduction
 40 different specimens
 Cover reportable range of method
What is
needed
 Duplicate measurements of each specimen
on each method
 Minimum of five days, prefer over 20
(since replicate testing is same)
How we
perform the
testing
Accuracy studies
Test results from the new
method against an existing
method which is known to
be accurate
Two or more samples in which the concentration of the
selected analyte concentrations spans but does not exceed
the analytical measuring interval of the assay.
Comparison of Method/ Instrument
Recovery of expected values
from assigned values
what is needed for accuracy studies ?
 A control sample or certified reference material
 Proficiency testing material
 Materials provided by the method manufacturer for verification of
trueness or quality control.
Method comparison
• WHEN IT IS
PERFORMED?
 To validate a new method being brought into
the lab, by demonstrating that it is
statistically identical to the method currently
in use.
HOW IT IS PERFORMED?
Assay about 20-40 patient samples on
both instruments. The specimens should
be somewhat evenly-distributed across
the analytes reportable range.
Purpose: To validate a new method being brought into the lab, by demonstrating that it is
statistically identical to the method currently in use.
Experiment Design Requirements:
Run 20-40 specimens that cover reportable range properly on both instruments.
Statistics:
Correlation coefficient(R)
SLOPE
INTERCEPT
Interpretation:
CORELATION COFICIENT SHOULD BE >0.9
95% confidence interval for the Deming Slope includes 1.000
95% confidence interval for the Deming Intercept includes 0.000
Alternate method comparison
Purpose:
The Two Instrument Comparison (2IC) procedure will satisfy the CLIA requirement for a lab to compare
instruments performing the same test on a semi-annual basis
Experiment Design:
Select 5-10 Specimens that cover reportable range and run on both instruments one time.
Data Requirements:
 5-10 reading of specimens
 Total allowable error
 Reportable range
Statistics:
 Average error index
 Slope
 Intercept
 standard error estimate
Interpretation:
Test passes, when error index of each pair (x-y) is between 1.0 to -1.0
Test fails ,when error index of any pair greater than 1.0 or less than -1.0.
Two instrument comparison
Purpose: Multiple Instrument Comparison (MIC) compares 3 or more instruments to determine whether
they are within Total Allowable Error (TEa) of the target.
Experiment Design Requirements:
 Select 3-19 instrument and run 3-5 specimens on each instrument that cover reportable range of test.
 Select one instrument as a target instrument.
Data Requirements:
 3-5 reading of each instrument
 Total allowable error
 Reportable range
Statistics:
 OBSERVE ERROR
 ERROR INDEX
 ALLOWABLE ERROR
Interpretation:
The experiment passes if every non target instrument is within error index limit of -1 to 1 .
Multi instrument comparison
Reportable Range / Linearity
Lowest and highest test results that are reliable
Especially important with two point calibrations
Analytical Measurement Range (AMR) and derived Clinical Reportable Range (CRR)
Introduction
What is
needed
How we
perform the
testing
Material manufactured specially for linearity checking.
CAP linearity survey or validation materials
Quality control or calibration material.
Single Patient samples.
Pool patient sample.
Spiked patient samples
Run 3-11 (5 is sufficient) specimens in triplicate with known concentration
spread across the reportable range; ideally the lowest and highest
specimen should challenge the limit of range.
Verifying reportable range
• AMR must be verified before method introduced, and at least
every 6 months (and after recalibration or major maintenance)
while in use
• CRR is a clinical decision by lab director, and does not require
experiments or re-validation; however, dilution or
concentration protocols must be specified in methods
How we evaluate linearity ?
 Reportable/Analytical measuring range(linearity) is verified if two
conditions are met:
 Assigned values of the lowest and highest specimen should be
within proximity limits of the reportable range limit.
 These two specimens are acceptably accurate with respect to total
allowable error.
Experiment Design :
 Select 3-5 specimens that cover reportable range/AMR and run 3-5 times each specimen
Data In put Requirements :
 Low and high reportable range of analyte
 Proximity limits
 3-5 reading of each specimens
 Target value of each specimen(mean)
 Allowable error
Statistics
 Mean
 Slope
 Intercept
 Error
 Percent
 Recovery
Interpretation :
 The midpoints of target ranges for the lowest and highest specimens respectively are with in
the proximity limit s of the reportable range limits
 These two specimens also pass accuracy.
 The method is linear if it is possible to draw straight line that passes within a user defined
allowable error of each specimen point.
Reference Intervals
 Normal range in healthy population
 Used for diagnosis/clinical interpretation of results
Introduction
• Test and compare to manufacturer: If all 20 specimens fall within the specified range, the
reference ranges have been verified and you can adopt manufacturer suggestions and
incorporate into your SOP. If not, need to establish reference ranges for your population
(240 specimens: 120 each of male and female).
• Another lab may have established reference ranges that can be used for verification
purposes; must be documented.
What is
needed
How we
perform the
testing
Enter the readings in EP evualtor along with, the
"proposed" reference interval that is to be verified.
PURPOSE: Reference interval verification with respect to population
Experiment Design Requirements:
Select 20 specimens of healthy individuals and run one time per specimen
Data Requirements:
 20 reading of health individual specimens
 Proposed Reference interval range
Statistics:
 MEAN
 SD
 MEDIAN
 RANGE
 Frequency
Interpretation:
If more than 10% of results are out side the proposed reference interval which mean verification fail,
otherwise passes.
Sensitivity
 Lowest reliable value; lower limit of
detection, especially of interest in drug testing
and tumor markers
 Different terminologies used by different
manufacturers
Introduction
 Blank solution: ( often use the zero calibrator)
 Low level of positive sample (slightly above
the manufacture's stated lowest detection limit)
What is
needed
 Run 20 blanks or low level samples;
How we
perform the
testing
Purpose: To verify the vendor claim sensitivity
Experiment Design Requirements :
 Replicate response measurements are made for two specimens
 blank or zero concentration sample minimum 10 replicate
 And 2nd sample of known low concentration minimum 3 replicate
Data Requirements :
 10 reading of zero concentration sample
 3 reading of low concentration sample
 manufacturer’s claim sensitivity
Statistics:
 Mean
 SD
 2 SD 95% confidence interval for Limit of Blank
Interpretation :
 Manufacture sensitivity claim is verified when the computed LOB is less than manufacturer ‘s
claim.
Specificity
 Determination of how well a method measures the
analyte of interest accompanied by potential
interfering materials
Introduction
 Standard solutions, participant specimens
or pools
 Interferer solutions (standard solutions, if
possible; otherwise, pools or specimens)
added at high concentrations
What is
needed
 Duplicate measurements.
 The lab can use the manufacturer’s provided list
How we
perform the
testing
Specificity: How We Evaluate the Data
 Tabulate results for pairs of samples
(dilution and interferent)
 Calculate means for each (dilution
and interferent)
 Calculate the differences
 Calculate the average interference of
all specimens tested at a given
concentration of interference
Carry Over
 Carryover” in laboratory testing, is defined as “the
contamination of a specimen by the previous one”.
 Select specimens for the analytes to be tested.
 Select one patient/control specimen with a very low level of
the analyte and one with a very high level.
 Select specimens with enough volume so that they can each be
run approximately 10 to 11 times.
WHAT IS NEEDED ?
when to perform carry over studies?
 Study must be performed, as applicable, as a part of initial
evaluation of an instrument.
 Study is repeated after major maintenance or repair of the
pipetting assembly of instrument.
 Evaluation for carryover is not required for automatic
pipettes that use disposable tips.
 The instrument must be dedicated to the analysis of one
analyte during this experiment and must do this experiment
for one analyte at a time.
 Routine performance of tests must be suspended.
How to perform carry over?
Run in following order :
 3 Low specimens
 2 High specimens
 1Low specimen
 2 High specimens
 4 Low specimens
 2 High specimens
 1 Low Specimen
 2 High specimens
 1 Low Specimen
 2 High specimens
 1 Low Specimen
Experiment design: Two specimen are prepared ,one with very high concentration and one with very
low concentration .these specimens are aliquot out in to a total of 21 samples :11 with low and 10 with
high concentration.
Run sample in following sequence on analyzer.
LLLHHLHHLLLLHHLHHLHHL
Data Requirements:
21 reading of low and high specimen as above sequence.
Statistics
 SD
 Mean
 Error Limit
 Carry over
carry over: The mean of H-L results minus the mean of L-L results
Error limit: Three times the SD of L-L results
Interpretation :Carry over test passes if carry over is less than error limit.
Validation for qualitative tests:
Precision
Accuracy
Precision for qualitative assay
 Runs of specimens with analyte concentrations near the cutoff
point .
 Three specimens, one at cutoff, one just below cutoff, and one
just above cutoff (± 20% recommended) .
 Replicate measurements of each of three specimens (20 each,
minimum).
How to evaluate?
 The results obtained from the negative and positive controls
will be used to calculate the CV and compared to the
manufacturer’s claims for reproducibility.
 The laboratory CV should be less than or equal to the
manufacturer’s stated CV. In the event that an assay does not
perform as expected
What is needed for accuracy studies for
qualitative testing?
 Samples with known values, such as :
proficiency testing samples or commercial standards, may be
used as the reference method.
 use of EQA samples or other commercially prepared
reference material with known values.
accuracy/method comparison for qualitative
testing
What is needed ?
• A minimum of 10 samples for each expected result.
For example, if a test method gives results of
“Positive/Negative”, the accuracy study must include 10
known positives and 10 known negatives.
• Two levels of quality control must be run each day that testing
is performed, not including controls internal to the kit
cartridge/testing device.
How it is performed?
• The performance of qualitative tests is most commonly
described in terms of sensitivity and specificity.
• By using a contingency table:
Method being Validated
Diagnostic Sensitivity and Specificity
(Results from Comparison Study) Total
Positive Negative
Positive # true positive (TP) # false positive (FP) TP+FP
Negative # false negative (FN) # true negative (TN) FN+TN
Total TP+FN FP+TN N
How it is evaluated?
 Compare the results calculated above with the manufacturer’s
stated claims for Sensitivity, Specificity and Agreement found
in the test kit package insert.
 Results must be equal to, or greater than, the manufacturer’s
claims for the method to be considered accurate
PURPOSE: To compare two qualitative method are correlated to each other
Experiment Design Requirements:
Run 20-40 specimen from both method which consist off positive ,negative and borderline results
equally.
Data Requirements :
 20-40 reading of specimens
Statistics:
 Total agreement
 Positive agreement
 Negative agreement
 Cohen kappa agreement
Interpretation :
Cohen kappa agreement should be >75% passes.
Total agreement should be >90%
qualitative/semi qualitatine method comparision
Thank you !

More Related Content

What's hot

Quality Control In Clinical Laboratory
Quality Control In Clinical LaboratoryQuality Control In Clinical Laboratory
Quality Control In Clinical Laboratory
Dr. Rajesh Bendre
 
Internal quality control
Internal quality controlInternal quality control
Internal quality control
Syed Basheer
 
Basics of laboratory internal quality control, Ola Elgaddar, 2012
Basics of laboratory internal quality control, Ola Elgaddar, 2012Basics of laboratory internal quality control, Ola Elgaddar, 2012
Basics of laboratory internal quality control, Ola Elgaddar, 2012
Ola Elgaddar
 
Quality Control in Pathological Laboratory
Quality Control in Pathological LaboratoryQuality Control in Pathological Laboratory
Quality Control in Pathological Laboratory
sanarehman8159
 
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain ShamsQuality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Adel Elazab Elged
 
(IQC) - Internal Quality Control.pptx
(IQC) - Internal Quality Control.pptx(IQC) - Internal Quality Control.pptx
(IQC) - Internal Quality Control.pptx
Dr.Rajeev Ranjan
 
Clinical lab qc sethu
Clinical lab qc sethuClinical lab qc sethu
Clinical lab qc sethu
subramaniam sethupathy
 
Quality control in the medical laboratory
Quality control in the medical laboratoryQuality control in the medical laboratory
Quality control in the medical laboratoryAdnan Jaran
 
Quality control
Quality controlQuality control
Quality control
Pavalaveelzi C.M
 
Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory
Randox
 
Quality assurance is necessary in blood banking
Quality assurance is necessary in blood bankingQuality assurance is necessary in blood banking
Quality assurance is necessary in blood banking
Dr Shahida Baloch
 
Quality assurance
Quality assuranceQuality assurance
Quality assurance
Dr Nidhi Rai Gupta
 
Quality control
Quality controlQuality control
Quality control
Abhra Ghosh
 
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Randox
 
quality control in clinical pathology
quality control in clinical pathologyquality control in clinical pathology
quality control in clinical pathology
Ishaque Vadakkethil
 
ISO 15189 MEDICAL LABORTORIES REQUIRMENTS FOR QUALITY AND COMPETENCE
ISO 15189 MEDICAL LABORTORIES  REQUIRMENTS  FOR QUALITY AND  COMPETENCEISO 15189 MEDICAL LABORTORIES  REQUIRMENTS  FOR QUALITY AND  COMPETENCE
ISO 15189 MEDICAL LABORTORIES REQUIRMENTS FOR QUALITY AND COMPETENCE
Shahid Nawaz
 
Quality assurance in blood banking
Quality assurance in blood bankingQuality assurance in blood banking
Quality assurance in blood banking
Dr Shahida Baloch
 
Laboratory Internal Quality Control presentation master revision, 2014
Laboratory Internal Quality Control presentation master revision, 2014Laboratory Internal Quality Control presentation master revision, 2014
Laboratory Internal Quality Control presentation master revision, 2014
Adel Elazab Elged
 
Internal quality control (IQC) in coagulation lab
Internal quality control (IQC) in coagulation labInternal quality control (IQC) in coagulation lab
Internal quality control (IQC) in coagulation lab
Ankit Raiyani
 

What's hot (20)

Quality Control In Clinical Laboratory
Quality Control In Clinical LaboratoryQuality Control In Clinical Laboratory
Quality Control In Clinical Laboratory
 
Method verification
Method verificationMethod verification
Method verification
 
Internal quality control
Internal quality controlInternal quality control
Internal quality control
 
Basics of laboratory internal quality control, Ola Elgaddar, 2012
Basics of laboratory internal quality control, Ola Elgaddar, 2012Basics of laboratory internal quality control, Ola Elgaddar, 2012
Basics of laboratory internal quality control, Ola Elgaddar, 2012
 
Quality Control in Pathological Laboratory
Quality Control in Pathological LaboratoryQuality Control in Pathological Laboratory
Quality Control in Pathological Laboratory
 
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain ShamsQuality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
 
(IQC) - Internal Quality Control.pptx
(IQC) - Internal Quality Control.pptx(IQC) - Internal Quality Control.pptx
(IQC) - Internal Quality Control.pptx
 
Clinical lab qc sethu
Clinical lab qc sethuClinical lab qc sethu
Clinical lab qc sethu
 
Quality control in the medical laboratory
Quality control in the medical laboratoryQuality control in the medical laboratory
Quality control in the medical laboratory
 
Quality control
Quality controlQuality control
Quality control
 
Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory
 
Quality assurance is necessary in blood banking
Quality assurance is necessary in blood bankingQuality assurance is necessary in blood banking
Quality assurance is necessary in blood banking
 
Quality assurance
Quality assuranceQuality assurance
Quality assurance
 
Quality control
Quality controlQuality control
Quality control
 
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?
 
quality control in clinical pathology
quality control in clinical pathologyquality control in clinical pathology
quality control in clinical pathology
 
ISO 15189 MEDICAL LABORTORIES REQUIRMENTS FOR QUALITY AND COMPETENCE
ISO 15189 MEDICAL LABORTORIES  REQUIRMENTS  FOR QUALITY AND  COMPETENCEISO 15189 MEDICAL LABORTORIES  REQUIRMENTS  FOR QUALITY AND  COMPETENCE
ISO 15189 MEDICAL LABORTORIES REQUIRMENTS FOR QUALITY AND COMPETENCE
 
Quality assurance in blood banking
Quality assurance in blood bankingQuality assurance in blood banking
Quality assurance in blood banking
 
Laboratory Internal Quality Control presentation master revision, 2014
Laboratory Internal Quality Control presentation master revision, 2014Laboratory Internal Quality Control presentation master revision, 2014
Laboratory Internal Quality Control presentation master revision, 2014
 
Internal quality control (IQC) in coagulation lab
Internal quality control (IQC) in coagulation labInternal quality control (IQC) in coagulation lab
Internal quality control (IQC) in coagulation lab
 

Similar to Clinical lab-method validation.ppt

ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdfANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
BALASUNDARESAN M
 
QA QC Program for Waste Water Analysis ppt
QA QC Program for Waste Water Analysis pptQA QC Program for Waste Water Analysis ppt
QA QC Program for Waste Water Analysis ppt
KrisnaBagtasos1
 
Seminar on introduction to validation
Seminar on introduction to validationSeminar on introduction to validation
Seminar on introduction to validation
vasantipatil5
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
roshankhetade2
 
Quality control.pptx
Quality control.pptxQuality control.pptx
Quality control.pptx
aditisikarwar2
 
Analytical Method Validation
Analytical Method ValidationAnalytical Method Validation
Analytical Method Validation
Soumyadarshi Choudhury
 
Accuracy and precision presentation
Accuracy and precision presentationAccuracy and precision presentation
Accuracy and precision presentation
SampatChoudhary4
 
HPLC validation.ppt
HPLC validation.pptHPLC validation.ppt
HPLC validation.ppt
Priyanka Yadav
 
How to Validate a New Test.pdf
How to Validate a New Test.pdfHow to Validate a New Test.pdf
How to Validate a New Test.pdf
HaythamHagrass
 
Analytical method validation as per ich and usp
Analytical method validation as per ich and usp Analytical method validation as per ich and usp
Analytical method validation as per ich and usp
shreyas B R
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
Sai Praveen Reddy
 
Validation of Analytical method.ppt
Validation of Analytical method.pptValidation of Analytical method.ppt
Validation of Analytical method.ppt
Priyanka Yadav
 
Method Validation: What Are Its Key Parameters
Method Validation:What Are Its Key ParametersMethod Validation:What Are Its Key Parameters
Method Validation: What Are Its Key Parameters
complianceonline123
 
Analytical Method Validation basics by Dr. A. Amsavel
Analytical Method Validation  basics by Dr. A. AmsavelAnalytical Method Validation  basics by Dr. A. Amsavel
Analytical Method Validation basics by Dr. A. Amsavel
Dr. Amsavel A
 
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
Nguyễn Thị Vân Anh
 
Validation methods.pptx
Validation methods.pptxValidation methods.pptx
Validation methods.pptx
BrindhaLakshmi2
 
Analytical Method Validation.pptx
Analytical Method Validation.pptxAnalytical Method Validation.pptx
Analytical Method Validation.pptx
Bholakant raut
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
Devipriya Viswambharan
 
Quality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistryQuality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistry
Dipesh Tamrakar
 
Analytical methods validation as per ich & usp
Analytical methods validation as per ich & uspAnalytical methods validation as per ich & usp
Analytical methods validation as per ich & usp
GANESH NIGADE
 

Similar to Clinical lab-method validation.ppt (20)

ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdfANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
 
QA QC Program for Waste Water Analysis ppt
QA QC Program for Waste Water Analysis pptQA QC Program for Waste Water Analysis ppt
QA QC Program for Waste Water Analysis ppt
 
Seminar on introduction to validation
Seminar on introduction to validationSeminar on introduction to validation
Seminar on introduction to validation
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Quality control.pptx
Quality control.pptxQuality control.pptx
Quality control.pptx
 
Analytical Method Validation
Analytical Method ValidationAnalytical Method Validation
Analytical Method Validation
 
Accuracy and precision presentation
Accuracy and precision presentationAccuracy and precision presentation
Accuracy and precision presentation
 
HPLC validation.ppt
HPLC validation.pptHPLC validation.ppt
HPLC validation.ppt
 
How to Validate a New Test.pdf
How to Validate a New Test.pdfHow to Validate a New Test.pdf
How to Validate a New Test.pdf
 
Analytical method validation as per ich and usp
Analytical method validation as per ich and usp Analytical method validation as per ich and usp
Analytical method validation as per ich and usp
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Validation of Analytical method.ppt
Validation of Analytical method.pptValidation of Analytical method.ppt
Validation of Analytical method.ppt
 
Method Validation: What Are Its Key Parameters
Method Validation:What Are Its Key ParametersMethod Validation:What Are Its Key Parameters
Method Validation: What Are Its Key Parameters
 
Analytical Method Validation basics by Dr. A. Amsavel
Analytical Method Validation  basics by Dr. A. AmsavelAnalytical Method Validation  basics by Dr. A. Amsavel
Analytical Method Validation basics by Dr. A. Amsavel
 
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
 
Validation methods.pptx
Validation methods.pptxValidation methods.pptx
Validation methods.pptx
 
Analytical Method Validation.pptx
Analytical Method Validation.pptxAnalytical Method Validation.pptx
Analytical Method Validation.pptx
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Quality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistryQuality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistry
 
Analytical methods validation as per ich & usp
Analytical methods validation as per ich & uspAnalytical methods validation as per ich & usp
Analytical methods validation as per ich & usp
 

Recently uploaded

.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
samahesh1
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
ranishasharma67
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
Ahmed Elmi
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
Sachin Sharma
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
ranishasharma67
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
priyabhojwani1200
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
ranishasharma67
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
Care Coordinations
 
The Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdfThe Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdf
AD Healthcare
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 

Recently uploaded (20)

.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
 
The Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdfThe Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdf
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 

Clinical lab-method validation.ppt

  • 1. Method Validation To understand College of American Pathologists (CAP) requirements of method validation in a clinical laboratory Dr. Sibtain Ahmed
  • 2. What is validation? • “Validation is the process of testing a measurement procedure to assess its performance and to determine whether that performance is acceptable.” [CLSI]
  • 3. Method Validation Why must we validate? When should we validate? What should we validate? What is method validation?
  • 4. What is Method Validation? –Method validation and/or verification is the process by which a method is determined to be fit for purpose and intended use. –Although method validation/verification are often used interchangeably, validation is usually performed on in-house and/or modified methods, while verification is taking a marketed/unmodified assay and verifying its performance.
  • 5. Purposes of Method Validation Studies  To quantifiably characterize system performance  To assess potential for error  To identify method-to-method differences  To meet regulatory guidelines
  • 6. When to Do Method Validation Studies  When considering purchasing a new system  When placing a new system into service  At regular intervals to assess on-going system performance  When troubleshooting questionable system performance
  • 7. Tests to Validate • Waived tests are approved by the FDA for home use and by definition are simple to perform (i.e., pregnancy test) – do not require validation. • Non-waived tests included moderately and highly complex tests – requires validation • Degree of validation/verification depends on status of the test method (FDA- approved/Non-FDA-approved/Modified/Unmodified) • Unmodified FDA-approved: using as intended by the manufacturer and licensed for use by the FDA • Modified or Non-FDA approved: using test kit for indications other than as intended by the manufacturer; not licensed for use by the FDA.
  • 8. The 6 Elements of Method Validation: •If FDA-approved/Unmodified – only Reportable Range, Precision, Accuracy and Reference Intervals need to be verified. •If Non-FDA approved/Modified – all 6 elements must be performed, including sensitivity and specificity.
  • 9. samples are analyzed according to any number of schemes depending upon the analyte availability: Twice a day in duplicate for 10 days. Once a day for 20 days. Twice a day in quadruplicate for 5 days. Select sufficient material at two levels:  Patient samples  QC material  Reference materials  Standards  Suitable materials that have a known value. Precision  Multiple measurements are close to each others i.e. Reproducibility  Gives information related to random error Introduction What is needed How we perform the testing
  • 10. Experiment Design : Run one sample 20 time once a day for within run precision and for between run precision run one sample 2-4 times per day. Data Input Requirements :  20 reading of single specimen,  allowable total error  allowable random error Statistics:  MEAN  SD  CV  2SD RANGE  SD GOAL Interpretation :The precision test pass if computed SD below the SD goal.
  • 11. Accuracy  How close to the true value Comparison of methods  Closeness of the agreement between the result of a measurement and a true value of the measurand. [CLSI] Gives information related to systematic error Introduction  40 different specimens  Cover reportable range of method What is needed  Duplicate measurements of each specimen on each method  Minimum of five days, prefer over 20 (since replicate testing is same) How we perform the testing
  • 12. Accuracy studies Test results from the new method against an existing method which is known to be accurate Two or more samples in which the concentration of the selected analyte concentrations spans but does not exceed the analytical measuring interval of the assay. Comparison of Method/ Instrument Recovery of expected values from assigned values
  • 13. what is needed for accuracy studies ?  A control sample or certified reference material  Proficiency testing material  Materials provided by the method manufacturer for verification of trueness or quality control.
  • 14. Method comparison • WHEN IT IS PERFORMED?  To validate a new method being brought into the lab, by demonstrating that it is statistically identical to the method currently in use. HOW IT IS PERFORMED? Assay about 20-40 patient samples on both instruments. The specimens should be somewhat evenly-distributed across the analytes reportable range.
  • 15. Purpose: To validate a new method being brought into the lab, by demonstrating that it is statistically identical to the method currently in use. Experiment Design Requirements: Run 20-40 specimens that cover reportable range properly on both instruments. Statistics: Correlation coefficient(R) SLOPE INTERCEPT Interpretation: CORELATION COFICIENT SHOULD BE >0.9 95% confidence interval for the Deming Slope includes 1.000 95% confidence interval for the Deming Intercept includes 0.000 Alternate method comparison
  • 16. Purpose: The Two Instrument Comparison (2IC) procedure will satisfy the CLIA requirement for a lab to compare instruments performing the same test on a semi-annual basis Experiment Design: Select 5-10 Specimens that cover reportable range and run on both instruments one time. Data Requirements:  5-10 reading of specimens  Total allowable error  Reportable range Statistics:  Average error index  Slope  Intercept  standard error estimate Interpretation: Test passes, when error index of each pair (x-y) is between 1.0 to -1.0 Test fails ,when error index of any pair greater than 1.0 or less than -1.0. Two instrument comparison
  • 17. Purpose: Multiple Instrument Comparison (MIC) compares 3 or more instruments to determine whether they are within Total Allowable Error (TEa) of the target. Experiment Design Requirements:  Select 3-19 instrument and run 3-5 specimens on each instrument that cover reportable range of test.  Select one instrument as a target instrument. Data Requirements:  3-5 reading of each instrument  Total allowable error  Reportable range Statistics:  OBSERVE ERROR  ERROR INDEX  ALLOWABLE ERROR Interpretation: The experiment passes if every non target instrument is within error index limit of -1 to 1 . Multi instrument comparison
  • 18. Reportable Range / Linearity Lowest and highest test results that are reliable Especially important with two point calibrations Analytical Measurement Range (AMR) and derived Clinical Reportable Range (CRR) Introduction What is needed How we perform the testing Material manufactured specially for linearity checking. CAP linearity survey or validation materials Quality control or calibration material. Single Patient samples. Pool patient sample. Spiked patient samples Run 3-11 (5 is sufficient) specimens in triplicate with known concentration spread across the reportable range; ideally the lowest and highest specimen should challenge the limit of range.
  • 19. Verifying reportable range • AMR must be verified before method introduced, and at least every 6 months (and after recalibration or major maintenance) while in use • CRR is a clinical decision by lab director, and does not require experiments or re-validation; however, dilution or concentration protocols must be specified in methods
  • 20. How we evaluate linearity ?  Reportable/Analytical measuring range(linearity) is verified if two conditions are met:  Assigned values of the lowest and highest specimen should be within proximity limits of the reportable range limit.  These two specimens are acceptably accurate with respect to total allowable error.
  • 21. Experiment Design :  Select 3-5 specimens that cover reportable range/AMR and run 3-5 times each specimen Data In put Requirements :  Low and high reportable range of analyte  Proximity limits  3-5 reading of each specimens  Target value of each specimen(mean)  Allowable error Statistics  Mean  Slope  Intercept  Error  Percent  Recovery Interpretation :  The midpoints of target ranges for the lowest and highest specimens respectively are with in the proximity limit s of the reportable range limits  These two specimens also pass accuracy.  The method is linear if it is possible to draw straight line that passes within a user defined allowable error of each specimen point.
  • 22. Reference Intervals  Normal range in healthy population  Used for diagnosis/clinical interpretation of results Introduction • Test and compare to manufacturer: If all 20 specimens fall within the specified range, the reference ranges have been verified and you can adopt manufacturer suggestions and incorporate into your SOP. If not, need to establish reference ranges for your population (240 specimens: 120 each of male and female). • Another lab may have established reference ranges that can be used for verification purposes; must be documented. What is needed How we perform the testing Enter the readings in EP evualtor along with, the "proposed" reference interval that is to be verified.
  • 23. PURPOSE: Reference interval verification with respect to population Experiment Design Requirements: Select 20 specimens of healthy individuals and run one time per specimen Data Requirements:  20 reading of health individual specimens  Proposed Reference interval range Statistics:  MEAN  SD  MEDIAN  RANGE  Frequency Interpretation: If more than 10% of results are out side the proposed reference interval which mean verification fail, otherwise passes.
  • 24. Sensitivity  Lowest reliable value; lower limit of detection, especially of interest in drug testing and tumor markers  Different terminologies used by different manufacturers Introduction  Blank solution: ( often use the zero calibrator)  Low level of positive sample (slightly above the manufacture's stated lowest detection limit) What is needed  Run 20 blanks or low level samples; How we perform the testing
  • 25. Purpose: To verify the vendor claim sensitivity Experiment Design Requirements :  Replicate response measurements are made for two specimens  blank or zero concentration sample minimum 10 replicate  And 2nd sample of known low concentration minimum 3 replicate Data Requirements :  10 reading of zero concentration sample  3 reading of low concentration sample  manufacturer’s claim sensitivity Statistics:  Mean  SD  2 SD 95% confidence interval for Limit of Blank Interpretation :  Manufacture sensitivity claim is verified when the computed LOB is less than manufacturer ‘s claim.
  • 26. Specificity  Determination of how well a method measures the analyte of interest accompanied by potential interfering materials Introduction  Standard solutions, participant specimens or pools  Interferer solutions (standard solutions, if possible; otherwise, pools or specimens) added at high concentrations What is needed  Duplicate measurements.  The lab can use the manufacturer’s provided list How we perform the testing
  • 27. Specificity: How We Evaluate the Data  Tabulate results for pairs of samples (dilution and interferent)  Calculate means for each (dilution and interferent)  Calculate the differences  Calculate the average interference of all specimens tested at a given concentration of interference
  • 28. Carry Over  Carryover” in laboratory testing, is defined as “the contamination of a specimen by the previous one”.  Select specimens for the analytes to be tested.  Select one patient/control specimen with a very low level of the analyte and one with a very high level.  Select specimens with enough volume so that they can each be run approximately 10 to 11 times. WHAT IS NEEDED ?
  • 29. when to perform carry over studies?  Study must be performed, as applicable, as a part of initial evaluation of an instrument.  Study is repeated after major maintenance or repair of the pipetting assembly of instrument.  Evaluation for carryover is not required for automatic pipettes that use disposable tips.  The instrument must be dedicated to the analysis of one analyte during this experiment and must do this experiment for one analyte at a time.  Routine performance of tests must be suspended.
  • 30. How to perform carry over? Run in following order :  3 Low specimens  2 High specimens  1Low specimen  2 High specimens  4 Low specimens  2 High specimens  1 Low Specimen  2 High specimens  1 Low Specimen  2 High specimens  1 Low Specimen
  • 31. Experiment design: Two specimen are prepared ,one with very high concentration and one with very low concentration .these specimens are aliquot out in to a total of 21 samples :11 with low and 10 with high concentration. Run sample in following sequence on analyzer. LLLHHLHHLLLLHHLHHLHHL Data Requirements: 21 reading of low and high specimen as above sequence. Statistics  SD  Mean  Error Limit  Carry over carry over: The mean of H-L results minus the mean of L-L results Error limit: Three times the SD of L-L results Interpretation :Carry over test passes if carry over is less than error limit.
  • 32. Validation for qualitative tests: Precision Accuracy
  • 33. Precision for qualitative assay  Runs of specimens with analyte concentrations near the cutoff point .  Three specimens, one at cutoff, one just below cutoff, and one just above cutoff (± 20% recommended) .  Replicate measurements of each of three specimens (20 each, minimum).
  • 34. How to evaluate?  The results obtained from the negative and positive controls will be used to calculate the CV and compared to the manufacturer’s claims for reproducibility.  The laboratory CV should be less than or equal to the manufacturer’s stated CV. In the event that an assay does not perform as expected
  • 35. What is needed for accuracy studies for qualitative testing?  Samples with known values, such as : proficiency testing samples or commercial standards, may be used as the reference method.  use of EQA samples or other commercially prepared reference material with known values.
  • 36. accuracy/method comparison for qualitative testing What is needed ? • A minimum of 10 samples for each expected result. For example, if a test method gives results of “Positive/Negative”, the accuracy study must include 10 known positives and 10 known negatives. • Two levels of quality control must be run each day that testing is performed, not including controls internal to the kit cartridge/testing device.
  • 37. How it is performed? • The performance of qualitative tests is most commonly described in terms of sensitivity and specificity. • By using a contingency table: Method being Validated Diagnostic Sensitivity and Specificity (Results from Comparison Study) Total Positive Negative Positive # true positive (TP) # false positive (FP) TP+FP Negative # false negative (FN) # true negative (TN) FN+TN Total TP+FN FP+TN N
  • 38. How it is evaluated?  Compare the results calculated above with the manufacturer’s stated claims for Sensitivity, Specificity and Agreement found in the test kit package insert.  Results must be equal to, or greater than, the manufacturer’s claims for the method to be considered accurate
  • 39. PURPOSE: To compare two qualitative method are correlated to each other Experiment Design Requirements: Run 20-40 specimen from both method which consist off positive ,negative and borderline results equally. Data Requirements :  20-40 reading of specimens Statistics:  Total agreement  Positive agreement  Negative agreement  Cohen kappa agreement Interpretation : Cohen kappa agreement should be >75% passes. Total agreement should be >90% qualitative/semi qualitatine method comparision

Editor's Notes

  1. What is Method Validation? Method validation and/or verification is the process by which a method is determined to be fit for purpose and intended use. Although method validation/verification are often used interchangeably, validation is usually performed on in-house and/or modified methods, while verification is taking a marketed/unmodified assay and verifying its performance. Why is it important? Different testing environment, need to demonstrate that the test method performs in your lab environment as the manufacturer states it should Need to prove to yourself that the results reported by the manufacturer are reliable. When? Initially, before releasing patient results, and after any manufacturer changes/modifications and/or movement of the equipment.
  2. Measure of the reproducibility of the assay. Provides information related to random error. How do you verify precision? Must repeat testing on 20 samples over one day (short term) and over a period of 20 days (long term). Within 20 days we hope to see good among of variation in terms of how the test performed and exposure to a variety of environmental conditions.
  3. How does the new method compare to the reference method or standard? Testing should be performed in duplicate over at least 5 days in order to account for analyzer variations over the specified time period. Precision gives you information related to random error; Accuracy gives you information related to systematic error.
  4. Linearity may be misnomer; hence the terminology of Analytical Measurement Range and derived Clinical Reportable Range.
  5. For each reagent or kit, need to establish reference intervals to assist clinicians in interpretation of results. Based on normal “healthy” population. Test and compare to manufacturer: If all 20 specimens fall within the specified range, the reference ranges have been verified and you can adopt manufacturer suggestions and incorporate into your SOP. If not, need to establish reference ranges for your population (240 specimens: 120 each of male and female). Another lab may have established reference ranges that can be used for verification purposes; must be documented.
  6. Not required for FDA approved/ unmodified assay. If FDA approved/Unmodified, information can be used directly and incorporated in the your SOP. Need to adopt values in your SOP as evidence for sponsor/audit.
  7. Ability of your method to accurately measure an analyte within the presence of potential interfering substances. Not required for FDA approved/ unmodified assay. If FDA approved/Unmodified, adopt values in your SOP as evidence for sponsor/audit.
  8. What else can cause interferences? Drugs/medication/hemolysis/lipemia. Run assay with specimen diluted with blank (saline) and compare to same specimen diluted with potential interfering substance.